1. Exclusive: Russia says foreign inquiries about its potential fast-track Covid-19 vaccine are pouring in. But questions abound  CNN
  2. India's first COVID-19 vaccine trial starts at 8 sites; volunteers are 'fine', say doctors. Latest updates  Livemint
  3. Covid-19 Vaccine  FYNTV FetchYourNews
  4. Johnson & Johnson claims its COVID-19 vaccine showed protection in single dose, starts trials  Business Today
  5. Johnson & Johnson Sees Solid Results From COVID-19 Vaccine Trial; Launches Human Study in U.S. and Europe  TheStreet
  6. View Full coverage on Google News
The spread of novel Corona Virus Disease (COVID-19) in Nigeria continues to record significant increase as the latest statistics provided by the Nigeria Centre for Disease Control reveal Nigeria now has 42,689 confirmed cases. On the 30th of July 2020, 481 new confirmed cases and 5 deaths were recorded in Nigeria, having carried out a…The spread of novel Corona Virus Disease (COVID-19) in Nigeria continues to record significant increase as the latest statistics provided by the Nigeria Centre for Disease Control reveal Nigeria now has 42,689 confirmed cases. On the 30th of July 2020, 481 new confirmed cases and 5 deaths were recorded in Nigeria, having carried out a…

COVID-19: WHO says there is no 'zero risk' for countries easing travel restrictions

The spread of novel Corona Virus Disease (COVID-19) in Nigeria continues to record significant increase as the latest statistics provided by the Nigeria Centre for Disease Control reveal Nigeria now has 42,689 confirmed cases. On the 30th of July 2020, 481 new confirmed cases and 5 deaths were recorded in Nigeria, having carried out a…The spread of novel Corona Virus Disease (COVID-19) in Nigeria continues to record significant increase as the latest statistics provided by the Nigeria Centre for Disease Control reveal Nigeria now has 42,689 confirmed cases. On the 30th of July 2020, 481 new confirmed cases and 5 deaths were recorded in Nigeria, having carried out a…

COVID-19: WHO says there is no 'zero risk' for countries easing travel restrictions

The European Union has warned member states of the risk of shortages of syringes, wipes and protective gear needed for potential mass vaccinations against COVID-19 and urged them to consider joint procurement, according to an EU document. The bloc has also asked EU governments to consider jointly buyingThe European Union has warned member states of the risk of shortages of syringes, wipes and protective gear needed for potential mass vaccinations against COVID-19 and urged them to consider joint procurement, according to an EU document. The bloc has also asked EU governments to consider jointly buying

EU warns of risk of syringe shortages for possible COVID-19 vaccine

Rohtak: Two weeks after starting the human trial of vaccine on three individuals, the Post Graduate Institute of Medical Sciences (PGIMS), Rohtak on F.Rohtak: Two weeks after starting the human trial of vaccine on three individuals, the Post Graduate Institute of Medical Sciences (PGIMS), Rohtak on F.

Human trial: PGIMS administers 2nd dose of vaccine to 3 persons | Chandigarh News - Times of India

Rohtak: Two weeks after starting the human trial of vaccine on three individuals, the Post Graduate Institute of Medical Sciences (PGIMS), Rohtak on F.Times of India brings the Latest & Top Breaking News on Politics and Current Affairs in India & around the World, Cricket, Sports, Business, Bollywood News and Entertainment, Science, Technology, Health & Fitness news & opinions from leading columnists.

Human trial: PGIMS administers 2nd dose of vaccine to 3 persons | Chandigarh News - Times of India

Johnson & Johnson's single-shot coronavirus vaccine has begun human trials

CNN reported critics said Russia was racing ahead with its vaccine because the Kremlin wants to be seen as a global scientific leader.CNN reported critics said Russia was racing ahead with its vaccine because the Kremlin wants to be seen as a global scientific leader.

CNN: Russia races to approve vaccine within next two weeks - Business Insider

Johnson & Johnson COVID-19 Vaccine Candidate Demonstrates Robust Protection in Pre-Clinical StudiesJohnson & Johnson’s (New Brunswick, NJ, USA) lead vaccine candidate has successfully protected monkeys against infection with SARS-CoV-2, the virus that causes COVID-19, in pre-clinical studies.

Johnson & Johnson COVID-19 Vaccine Candidate Demonstrates Robust Protection in Pre-Clinical Studies - COVID-19 - Hospimedica.com

Russia's health minister is preparing a mass vaccination campaign against the novel coronavirus for October, local news agencies reported on Saturday, after a vaccine completed clinical trials. Health Minister Mikhail Murashko said the Gamaleya Institute, a state research facility in Moscow, had completed clinical trials of the vaccine and paperwork is being prepared to register it, Interfax news agency reported.Russia's health minister is preparing a mass vaccination campaign against the novel coronavirus for October, local news agencies reported on Saturday, after a vaccine completed clinical trials. Health Minister Mikhail Murashko said the Gamaleya Institute, a state research facility in Moscow, had completed clinical trials of the vaccine and paperwork is being prepared to register it, Interfax news agency reported.

Russia preparing mass vaccination against coronavirus for October

First-in-human Phase 1/2a clinical trial now underway in United States and BelgiumFirst-in-human Phase 1/2a clinical trial now underway in United States and Belgium

J&J to commence Ph III trial of COVID-19 vaccine in Sept

Industry Global News24 - News solution that helps you connect and engage with target audiences in Business, Healthcare, Technology, Industry Latest News, Updated News, Latest trending News on industry across the world.

RUSSIAN COVID-19 VACCINE TO BE READY BY AUGUST-Industry Global News24

Russia is preparing to start a mass vaccination campaign against the novel coronavirus in October, Health Minister Mikhail Murashko said on Saturday, RIA news agency reported.Russia is preparing to start a mass vaccination campaign against the novel coronavirus in October, Health Minister Mikhail Murashko said on Saturday, RIA news agency reported.

Russia plans mass vaccination against coronavirus from October, RIA reports - Reuters

Russian scientists would release all their findings in AugustRussian scientists would release all their findings in August

All volunteers developed coronavirus immunity after Russian vaccine trials — RDIF - World - TASS

All volunteers developed coronavirus immunity after Russian vaccine trials — RDIF

Advertisement Russia has denied what it calls false allegations on stealing the research work from Oxford University. U.K, Canada, and the U.S from the past couple of days have been reporting on Russia hacking the critical developments in making a vaccine for Coronavirus. Russia says it could come up with an effective vaccine as close […]

Russia Rejects Accusations Of Stealing Oxford Research On Coronavirus

Russia has denied what it calls false allegations on stealing the research work from Oxford University. U.K, Canada, and the U.S from the past couple of days have been reporting on Russia hacking the critical developments in making a vaccine for Coronavirus. Russia says it could come up with an effective vaccine as close as […]

Russia Rejects Accusations Of Stealing Oxford Research On Coronavirus

Mass vaccination against COVID-19 in Russia is scheduled to begin in October, Russian Minister of Health Mikhail Murashko said on Saturday.We plan that it is already wider , after all, we must more gradually enter the new system of assistance, it will have to be longer in October, Murashko told re ..Mass vaccination against COVID-19 in Russia is scheduled to begin in October, Russian Minister of Health Mikhail Murashko said on Saturday.We plan that it is already wider , after all, we must more gradually enter the new system of assistance, it will have to be longer in October, Murashko told re ..

Russian Health Ministers Says COVID-19 Vaccinations May Begin In October In Special Groups - UrduPoint

Researchers 'impressed but unsurprised' over Russia's Covid-19 vaccine developmentResearchers 'impressed but unsurprised' over Russia's Covid-19 vaccine development

Researchers 'impressed but unsurprised' over Russia's Covid-19 vaccine development

Stocks of the Johnson & Johnson Company remain unchanged even after announcement of the successful trial of the vaccine.Stocks of the Johnson & Johnson Company remain unchanged even after announcement of the successful trial of the vaccine.

Johnson & Johnson (JNJ) Stock Price Remains Unchanged Despite Promising Results of the Vaccine

Stocks of the Johnson & Johnson Company remain unchanged even after announcement of the successful trial of the vaccine.

Johnson & Johnson (JNJ) Stock Price Remains Unchanged Despite Promising Results of the Vaccine

In pre-clinical data recently published in Nature, Johnson & Johnson’s lead vaccine candidate for SARS-CoV-2, the virus that causes COVID-19, provoked strong antibody responses in non-human primates, subsequently blocking infection of their lungs. “We are excited to see these pre-clinical … Read More »

In primates, Johnson & Johnson COVID-19 vaccine provides strong protection after one dose - Homeland Preparedness News

Russia expects to start mass anti-coronavirus vaccinations, across the country, by October, the country’s health minister has said. Mikhail Murashko added that medical workers and teachers will be given first priority.Russia expects to start mass anti-coronavirus vaccinations, across the country, by October, the country’s health minister has said. Mikhail Murashko added that medical workers and teachers will be given first priority.

Russia aims to begin public Covid-19 vaccinations in October, starting with medical workers & teachers – Minister of Health — RT Russia News

* Stoffels said prior tests of this type of vaccine in other diseases found that a second shot significantly increases protection. * Stoffels said prior tests of this type of vaccine in other diseases found that a second shot significantly increases protection.

J&J starts human study of COVID-19 vaccine after promising monkey data - Business - Business Recorder

Russia Plans to Register World's First Coronavirus Vaccine By August

Russian Federation claims success in producing COVID-19 vaccine

Page UnavailablePage Unavailable

Page Unavailable - ABC News

J&J has started a Phase I/IIa clinical trial of its Covid-19 vaccine candidate, Ad26.COV2.S, in healthy volunteers across the US and Belgium.J&J has started a Phase I/IIa clinical trial of its Covid-19 vaccine candidate, Ad26.COV2.S, in healthy volunteers across the US and Belgium.

J&J begins first trial of Covid-19 vaccine after positive preclinical data

The Brussels-based European Biosafety Network (EBN) has warned that the arrival of a vaccine against the coronavirus Covid-19 could be met by a Europe-wideThe Brussels-based European Biosafety Network (EBN) has warned that the arrival of a vaccine against the coronavirus Covid-19 could be met by a Europe-wide shortage of adequate syringes and needles. T

Vaccination syringes and needles – EU's next shortage?

Russia is likely to go ahead with the approval of its COVID-19 vaccine without finishing the phase-3 human trials. Read on to know more.Russia is likely to go ahead with the approval of its COVID-19 vaccine without finishing the phase-3 human trials. Read on to know more.

COVID-19: Will Russia give the world the first vaccine against the pandemic?

The spread of novel Corona Virus Disease (COVID-19) in Nigeria continues to record significant increase as the latest statistics provided by the Nigeria Centre for Disease Control reveal Nigeria now has 42,689 confirmed cases. On the 30th of July 2020, 481 new confirmed cases and 5 deaths were recorded in Nigeria, having carried out a…The spread of novel Corona Virus Disease (COVID-19) in Nigeria continues to record significant increase as the latest statistics provided by the Nigeria Centre for Disease Control reveal Nigeria now has 42,689 confirmed cases. On the 30th of July 2020, 481 new confirmed cases and 5 deaths were recorded in Nigeria, having carried out a…

COVID-19: J&J starts vaccine trials on humans after success on monkeys

The spread of novel Corona Virus Disease (COVID-19) in Nigeria continues to record significant increase as the latest statistics provided by the Nigeria Centre for Disease Control reveal Nigeria now has 42,689 confirmed cases. On the 30th of July 2020, 481 new confirmed cases and 5 deaths were recorded in Nigeria, having carried out a…The spread of novel Corona Virus Disease (COVID-19) in Nigeria continues to record significant increase as the latest statistics provided by the Nigeria Centre for Disease Control reveal Nigeria now has 42,689 confirmed cases. On the 30th of July 2020, 481 new confirmed cases and 5 deaths were recorded in Nigeria, having carried out a…

COVID-19: J&J starts vaccine trials on humans after success on monkeys

Johnson & Johnson announced Thursday that a vaccine candidate currently in human trials has shown success in protecting monkeys from coronavirus. The company said the potential vaccine --... | July 30, 2020Johnson & Johnson announced Thursday that a vaccine candidate currently in human trials has shown success in protecting monkeys from coronavirus. The company said the potential vaccine --... | July 30, 2020

Johnson & Johnson : vaccine produces 'robust' immune response in monkeys | MarketScreener

This article is part of Harvard Medical School’s continuing coverage of medicine, biomedical research, medical education and policy related to the SARS-CoV-2 pandemic and the disease COVID-19.New research shows single-shot COVID-19 vaccine protects nonhuman primates

A Critical Step toward Protection | Harvard Medical School

The development of a safe and effective vaccine will likely be required to end the COVID-19 pandemic. A group of scientists, led by Beth Israel Deaconess Medical Center immunologist Dan H. Barouch, MD, PhD, now report that a leading candidate COVID-19 vaccine developed at BIDMC in collaboration with Johnson & Johnson raised neutralizing antibodies and robustly protected non-human primates against SARS-CoV-2, the virus that causes COVID-19.The development of a safe and effective vaccine will likely be required to end the COVID-19 pandemic. A group of scientists, led by Beth Israel Deaconess Medical Center immunologist Dan H. Barouch, MD, PhD, now report that a leading candidate COVID-19 vaccine developed at BIDMC in collaboration with Johnson & Johnson raised neutralizing antibodies and robustly protected non-human primates against SARS-CoV-2, the virus that causes COVID-19.

Novel vaccine candidate robustly protects non-human primates against SARS-CoV-2

Johnson & Johnson (JNJ) initiated first-in-human safety trials of its COVID-19 vaccine candidate after a single dose in pre-clinical studies showed “robust protection”.The pre-clinical study data disclosed that J&J’s investigational vector-based vaccine triggered a robust immune response and neutralizingJohnson & Johnson (JNJ) initiated first-in-human safety trials of its COVID-19 vaccine candidate after a single dose in pre-clinical studies showed “robust protection”.The pre-clinical study data disclosed that J&J’s investigational vector-based vaccine triggered a robust immune response and neutralizing

Johnson & Johnson Starts First Human Trials For Its Covid-19 Candidate

COVID-19 vaccine trial has commenced at Uttar Pradesh's Rana Hospital and Trauma Centre.The first phase of human trial of Covaxin was completed at PGIMS RohtakCOVID-19 vaccine trial has commenced at Uttar Pradesh's Rana Hospital and Trauma Centre.The first phase of human trial of Covaxin was completed at PGIMS Rohtak

India's first COVID-19 vaccine trial starts at 8 sites; volunteers are 'fine', say doctors. Latest updates

Daijiworld - A News portal linking West coast of India and the World

Experimental vaccine begins first-in-human trial this month

J&J’s COVID-19 vaccine generates positive pre-clinical results - PMLiVE

Studies involving COVID-19 vaccine candidates in monkeys show promise of an effective vaccine, but it will take large-scale human trials to know for sure if they work. Studies involving COVID-19 vaccine candidates in monkeys show promise of an effective vaccine, but it will take large-scale human trials to know for sure if they work.

2 New But Early Studies Suggest COVID-19 Vaccine Could Be Given In 1 Dose : Coronavirus Live Updates : NPR

Ravinder Saini Tribune News Service Rohtak, August 1 A total of 79 volunteers have so far been successfully administered the first dose of indigenous Covid-19 vaccine, Covaxin, at Pt Bhagwat Dayal A total of 79 volunteers have so far been successfully administered the first dose of indigenous Covid-19 vaccine, Covaxin, at Pt Bhagwat Dayal Sharma Post Graduate Institute of Medical Science here under the first phase of its human clinical trial. Three volunteers were given the vaccine of Friday.

Encouraging results in first phase, 3 volunteers given second dose of Covid vaccine at Rohtak PGI : The Tribune India

A leading COVID-19 vaccine candidate, successfully raised neutralizing antibodies in a group of non-human primates after a single shot.A leading COVID-19 vaccine candidate, successfully raised neutralizing antibodies in a group of non-human primates after a single shot.

COVID-19 vaccine candidate creates 'robust protection' from virus in primates - Study Finds

A leading candidate of Covid-19 vaccine developed by global healthcare company Johnson & Johnson raised neutralising antibodies and robustly protected monkeys against SARS-CoV-2, the virus that causes ...A leading candidate of Covid-19 vaccine developed by global healthcare company Johnson & Johnson raised neutralising antibodies and robustly protected monkeys against SARS-CoV-2, the virus that causes...

J and J vaccine cures monkey in a single shot

As the world is going through one of its toughest phases with the Covid-19 pandemic, world's first Corona vaccine produced by Russia is likely for publicAs the world is going through one of its toughest phases with the Covid-19 pandemic, world's first Corona vaccine produced by Russia is likely for public

World's First Corona Vaccine by August - Gulte

An experimental coronavirus vaccine developed by Johnson & Johnson protected monkeys from infection in a new study. It is the second vaccine candidate to show promising results in monkeys this week.An experimental coronavirus vaccine developed by Johnson & Johnson protected monkeys from infection in a new study. It is the second vaccine candidate to show promising results in monkeys this week.

Johnson & Johnson’s coronavirus vaccine protects monkeys, study finds - The Virginian-Pilot - The Virginian-Pilot

Attention Required! | Cloudflare